​

Palisade Bio (PALI) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

PALI Stock Forecast

Palisade Bio (PALI) stock forecast, based on 1 Wall Street analysts, predicts a 12-month average price target of $1.50, with a high of $1.50 and a low of $1.50. This represents a 4.90% increase from the last price of $1.43.

- $1 $2 $3 $4 $5 $6 $7 High: $1.5 Avg: $1.5 Low: $1.5 Last Closed Price: $1.43

PALI Stock Rating

Palisade Bio stock's rating consensus is Buy, based on 1 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 1 0 1 Strong Sell Sell Hold Buy Strong Buy

PALI Forecast vs Benchmarks

TypeNameUpside
StockPalisade Bio4.90%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.43$1.43$1.43
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2512---3
Dec, 2412---3
Nov, 2412---3
Oct, 2411---2
Sep, 2411---2
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 17, 2023Naz RahmanMaxim Group$1.50$9.07-83.46%4.90%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Mar 30, 2023Maxim GroupBuyupgrade

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-27.01-----
Avg Forecast$-28.14$-11.97$-3.66$-3.72$-4.79$-5.85
High Forecast$-28.14$-12.62$-5.04$-6.21$-8.46$-5.85
Low Forecast$-28.14$-11.31$-2.27$-1.23$-2.29$-5.85
Surprise %-4.02%-----

Revenue Forecast

$0 $10M $20M $30M $40M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$250.00K-----
Avg Forecast$250.00K$8.21M$12.15M$27.87M$47.71M$48.23K
High Forecast$250.00K$8.21M$12.15M$27.87M$47.71M$48.23K
Low Forecast$250.00K$8.21M$12.15M$27.87M$47.71M$48.23K
Surprise %------

Net Income Forecast

$-15M $-12M $-9M $-6M $-3M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-12.32M-----
Avg Forecast$-12.83M$-5.46M$-1.67M$-1.70M$-2.45M$-2.67M
High Forecast$-12.83M$-5.76M$-2.30M$-2.83M$-3.86M$-2.67M
Low Forecast$-12.83M$-5.16M$-1.04M$-560.90K$-1.04M$-2.67M
Surprise %-4.04%-----

PALI Forecast FAQ

Is Palisade Bio stock a buy?

Palisade Bio stock has a consensus rating of Buy, based on 1 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Palisade Bio is a favorable investment for most analysts.

What is Palisade Bio's price target?

Palisade Bio's price target, set by 1 Wall Street analysts, averages $1.5 over the next 12 months. The price target range spans from $1.5 at the low end to $1.5 at the high end, suggesting a potential 4.90% change from the previous close price of $1.43.

How does Palisade Bio stock forecast compare to the average forecast of its sector, industry, and investment themes?

Palisade Bio stock forecast shows a 4.90% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Palisade Bio over the past three months?

  • January 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Palisade Bio’s EPS forecast?

Palisade Bio's average annual EPS forecast for its fiscal year ending in December is -11.97 for 2024, a -55.68% decrease from the reported $-27.01 in 2023. The prediction for 2025 is $-3.66, $-3.72 for 2026, $-4.79 for 2027, and $-5.85 for 2028.

What is Palisade Bio’s revenue forecast?

Palisade Bio's average annual revenue forecast for its fiscal year ending in December is $8.21M for 2024, a 3185.20% increase from the reported $250K in 2023. The forecast for 2025 is $12.15M, $27.87M for 2026, $47.71M for 2027, and $48.23K for 2028.

What is Palisade Bio’s net income forecast?

For its fiscal year ending in December, Palisade Bio's average annual net income forecast is $-5.456M for 2024, reflecting a -55.70% decrease from the reported $-12.316M in 2023. The projection for 2025 is $-1.667M, $-1.696M for 2026, $-2.45M for 2027, and $-2.665M for 2028.